Novel PET Agent to Identify Patients for Targeted Therapies
Novel PET Agent Effectively Detects Multiple Cancers, Identifies Patients for [...]
Dr Acosta’s testimonial : A journey living with prostate cancer
Discover Dr. Fernando Acosta’s treatment journey with radiotheranostics in his [...]
SNMMI 2002 Image of the Year
SNMMI Image of the Year 2022: PET/CT Biomarker Predicts Post-MI [...]
Theranostics continue to gain momentum
Article by Richard Zimmermann, President & Founder of the Oncidium [...]
SNMICON 2019
Event: Oncidium Talk during SNMICOM Date: 14 December 2019 Time: [...]